{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:13:43Z","timestamp":1787678023055,"version":"build-2784847793"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.phrs.2023.106740","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T14:36:32Z","timestamp":1679409392000},"page":"106740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["A novel lonidamine derivative targeting mitochondria to eliminate cancer stem cells by blocking glutamine metabolism"],"prefix":"10.1016","volume":"190","author":[{"given":"Qiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangling","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-yang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangliang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.phrs.2023.106740_bib1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41571-019-0293-2","article-title":"Targeting signalling pathways and the immune microenvironment of cancer stem cells \u2014 a clinical update","volume":"17","author":"Clara","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106740_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","article-title":"Targeting cancer stem cell pathways for cancer therapy","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2023.106740_bib3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41565-020-00793-0","article-title":"A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells","volume":"16","author":"Shen","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106740_bib4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1021\/acs.accounts.1c00635","article-title":"Rational design of nanotherapeutics based on the five features principle for potent elimination of cancer stem cells","volume":"55","author":"Zhang","year":"2022","journal-title":"Acc. Chem. Res."},{"issue":"10","key":"10.1016\/j.phrs.2023.106740_bib5","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/nchem.2778","article-title":"Salinomycin kills cancer stem cells by sequestering iron in lysosomes","volume":"9","author":"Mai","year":"2017","journal-title":"Nat. Chem."},{"key":"10.1016\/j.phrs.2023.106740_bib6","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3389\/fonc.2018.00452","article-title":"Doxycycline, an inhibitor of mitochondrial biogenesis, effectively reduces cancer stem cells (CSCs) in early breast cancer patients: a clinical pilot study","volume":"8","author":"Scatena","year":"2018","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.phrs.2023.106740_bib7","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1080\/15384101.2018.1467679","article-title":"Mitostemness","volume":"17","author":"Cuy\u00e0s","year":"2018","journal-title":"Cell Cycle"},{"issue":"12","key":"10.1016\/j.phrs.2023.106740_bib8","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/bjc.2016.152","article-title":"Hallmarks of cancer stem cell metabolism","volume":"114","author":"Sancho","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.phrs.2023.106740_bib9","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1042\/BCJ20170164","article-title":"Cancer stem cells (CSCs): metabolic strategies for their identification and eradication","volume":"475","author":"De Francesco","year":"2018","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.phrs.2023.106740_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cmet.2017.05.016","article-title":"Mitochondrial dynamics in regulating the unique phenotypes of cancer and stem cells","volume":"26","author":"Chen","year":"2017","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.phrs.2023.106740_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cmet.2018.06.006","article-title":"Targeting breast cancer stem cell state equilibrium through modulation of redox signaling","volume":"28","author":"Luo","year":"2018","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.phrs.2023.106740_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.molcel.2017.09.022","article-title":"Mitophagy controls the activities of tumor suppressor p53 to regulate hepatic cancer stem cells","volume":"68","author":"Liu","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2023.106740_bib13","doi-asserted-by":"crossref","first-page":"11029","DOI":"10.18632\/oncotarget.2789","article-title":"Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1\/2 inhibition","volume":"5","author":"Lamb","year":"2014","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.phrs.2023.106740_bib14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.stem.2021.02.013","article-title":"Targeting energy metabolism in cancer stem cells: progress and challenges in leukemia and solid tumors","volume":"28","author":"Jones","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10.1016\/j.phrs.2023.106740_bib15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5483\/BMBRep.2018.51.7.112","article-title":"Cancer stem cell metabolism: target for cancer therapy","volume":"51","author":"Chae","year":"2018","journal-title":"BMB Rep."},{"issue":"8","key":"10.1016\/j.phrs.2023.106740_bib16","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.trecan.2021.04.003","article-title":"Enhancing the efficacy of glutamine metabolism inhibitors in cancer therapy","volume":"7","author":"Yang","year":"2021","journal-title":"Trends Cancer"},{"issue":"4","key":"10.1016\/j.phrs.2023.106740_bib17","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"15","key":"10.1016\/j.phrs.2023.106740_bib18","first-page":"567","article-title":"A phase Ib trial of CB-839 (telaglenastat) in combination with radiation therapy and temozolomide in patients with IDH-mutated diffuse astrocytoma and anaplastic astrocytoma (NCT03528642)","volume":"37","author":"Kizilbash","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"6468","key":"10.1016\/j.phrs.2023.106740_bib19","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1126\/science.aav2588","article-title":"Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion","volume":"366","author":"Leone","year":"2019","journal-title":"Science"},{"issue":"7239","key":"10.1016\/j.phrs.2023.106740_bib20","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature07823","article-title":"c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism","volume":"458","author":"Gao","year":"2009","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.phrs.2023.106740_bib21","first-page":"151","article-title":"Mechanism of antineoplastic activity of lonidamine","volume":"1866","author":"Nath","year":"2016","journal-title":"Biochim. Biophys. Acta BBA Rev. Cancer"},{"issue":"3","key":"10.1016\/j.phrs.2023.106740_bib22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0959-8049(00)00400-7","article-title":"Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study","volume":"37","author":"De Lena","year":"2001","journal-title":"Eur. J. Cancer"},{"issue":"9","key":"10.1016\/j.phrs.2023.106740_bib23","doi-asserted-by":"crossref","first-page":"1904697","DOI":"10.1002\/adfm.201904697","article-title":"Sequential enzyme activation of a \u201cPro-Staramine\u201d-based nanomedicine to target tumor mitochondria","volume":"30","author":"Du","year":"2020","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.phrs.2023.106740_bib24","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/s41467-019-10042-1","article-title":"Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat. Commun."},{"issue":"50","key":"10.1016\/j.phrs.2023.106740_bib25","doi-asserted-by":"crossref","first-page":"43498","DOI":"10.1021\/acsami.7b14577","article-title":"Mitochondrial-targeting lonidamine-doxorubicin nanoparticles for synergistic chemotherapy to conquer drug resistance","volume":"9","author":"Liu","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"15","key":"10.1016\/j.phrs.2023.106740_bib26","doi-asserted-by":"crossref","first-page":"10043","DOI":"10.1021\/acs.chemrev.7b00042","article-title":"Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications","volume":"117","author":"Zielonka","year":"2017","journal-title":"Chem. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2023.106740_bib27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1158\/1940-6207.CAPR-20-0425","article-title":"Mitochondria as a novel target for cancer chemoprevention: emergence of mitochondrial-targeting agents","volume":"14","author":"Huang","year":"2021","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.phrs.2023.106740_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113528","article-title":"A novel selective mitochondrial-targeted curcumin analog with remarkable cytotoxicity in glioma cells","volume":"221","author":"Shi","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"22","key":"10.1016\/j.phrs.2023.106740_bib29","doi-asserted-by":"crossref","first-page":"9170","DOI":"10.1021\/jm4012438","article-title":"A selective mitochondrial-targeted chlorambucil with remarkable cytotoxicity in breast and pancreatic cancers","volume":"56","author":"Millard","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2023.106740_bib30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.isci.2018.04.013","article-title":"Mitochondria-targeted honokiol confers a striking inhibitory effect on lung cancer via inhibiting complex I activity","volume":"3","author":"Pan","year":"2018","journal-title":"iScience"},{"issue":"14","key":"10.1016\/j.phrs.2023.106740_bib31","doi-asserted-by":"crossref","first-page":"9955","DOI":"10.1021\/acs.jmedchem.2c00640","article-title":"A mitochondria-targeted phenylbutyric acid prodrug confers drastically improved anticancer activities","volume":"65","author":"Huang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2023.106740_bib32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/bjc.2011.9","article-title":"Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease","volume":"104","author":"Kang","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.phrs.2023.106740_bib33","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1101\/gad.1061803","article-title":"In vitro propagation and transcriptional profiling of human mammary stem\/progenitor cells","volume":"17","author":"Dontu","year":"2003","journal-title":"Genes Dev."},{"issue":"8","key":"10.1016\/j.phrs.2023.106740_bib34","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nmat3361","article-title":"Soft fibrin gels promote selection and growth of tumorigenic cells","volume":"11","author":"Liu","year":"2012","journal-title":"Nat. Mater."},{"issue":"2","key":"10.1016\/j.phrs.2023.106740_bib35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/cas.14285","article-title":"Cancer stem-like cells with hybrid epithelial\/mesenchymal phenotype leading the collective invasion","volume":"111","author":"Quan","year":"2020","journal-title":"Cancer Sci."},{"issue":"12","key":"10.1016\/j.phrs.2023.106740_bib36","first-page":"5059","article-title":"Role of cancer stem cell marker CD44 in gastric cancer: a meta-analysis","volume":"7","author":"Wang","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"13","key":"10.1016\/j.phrs.2023.106740_bib37","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1158\/0008-5472.CAN-12-3801","article-title":"Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production","volume":"73","author":"Hiraga","year":"2013","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.phrs.2023.106740_bib38","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12032-013-0503-1","article-title":"Sox2 expression predicts poor survival of hepatocellular carcinoma patients and it promotes liver cancer cell invasion by activating Slug","volume":"30","author":"Sun","year":"2013","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106740_bib39","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/s41467-021-22594-2","article-title":"Mitochondrion-specific dendritic lipopeptide liposomes for targeted sub-cellular delivery","volume":"12","author":"Jiang","year":"2021","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.phrs.2023.106740_bib40","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1073\/pnas.88.9.3671","article-title":"Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1","volume":"88","author":"Smiley","year":"1991","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5381","key":"10.1016\/j.phrs.2023.106740_bib41","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis","volume":"281","author":"Green","year":"1998","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.phrs.2023.106740_bib42","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.cr.7290049","article-title":"DNA fragmentation in apoptosis","volume":"10","author":"Zhang","year":"2000","journal-title":"Cell Res."},{"key":"10.1016\/j.phrs.2023.106740_bib43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1042\/bse0380009","article-title":"Caspases and apoptosis","volume":"38","author":"Salvesen","year":"2002","journal-title":"Essays Biochem."},{"issue":"10","key":"10.1016\/j.phrs.2023.106740_bib44","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrc3365","article-title":"Mitochondria and cancer","volume":"12","author":"Wallace","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2023.106740_bib45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3389\/fphar.2019.00203","article-title":"Metabolism-based therapeutic strategies targeting cancer stem cells","volume":"10","author":"Jagust","year":"2019","journal-title":"Front Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2023.106740_bib46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12282-009-0176-y","article-title":"Breast cancer stem cells","volume":"17","author":"Kai","year":"2010","journal-title":"Breast Cancer"},{"key":"10.1016\/j.phrs.2023.106740_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101458","article-title":"Hyperbaric oxygen regulates tumor mechanics and augments Abraxane and gemcitabine antitumor effects against pancreatic ductal adenocarcinoma by inhibiting cancer-associated fibroblasts","volume":"44","author":"Wang","year":"2022","journal-title":"Nano Today"},{"issue":"14","key":"10.1016\/j.phrs.2023.106740_bib48","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1158\/0008-5472.CAN-05-0592","article-title":"Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2(+) and ABCG2(-) cancer cells are similarly tumorigenic","volume":"65","author":"Patrawala","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2023.106740_bib49","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/396076","article-title":"Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance","volume":"2011","author":"Moore","year":"2011","journal-title":"J. Oncol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106740_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.72","article-title":"A CD44v+ subpopulation of breast cancer stem-like cells with enhanced lung metastasis capacity","volume":"8","author":"Hu","year":"2017","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.phrs.2023.106740_bib51","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrclinonc.2015.73","article-title":"Clinical management of breast cancer heterogeneity","volume":"12","author":"Zardavas","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.phrs.2023.106740_bib52","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Mokhtari","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.phrs.2023.106740_bib53","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1172\/JCI75836","article-title":"Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis","volume":"125","author":"Xiang","year":"2015","journal-title":"J. Clin. Investig."},{"issue":"4 Suppl 3","key":"10.1016\/j.phrs.2023.106740_bib54","first-page":"1","article-title":"Clinical toxicities encountered with paclitaxel (Taxol)","volume":"20","author":"Rowinsky","year":"1993","journal-title":"Semin. Oncol."},{"issue":"5","key":"10.1016\/j.phrs.2023.106740_bib55","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1023\/A:1009616228304","article-title":"Role of reactive oxygen species (ROS) in","volume":"5","author":"Simon","year":"2000","journal-title":"Apoptosis induction, Apoptosis"},{"key":"10.1016\/j.phrs.2023.106740_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101248","article-title":"Hyperbaric oxygen regulates tumor microenvironment and boosts commercialized nanomedicine delivery for potent eradication of cancer stem-like cells","volume":"40","author":"Liu","year":"2021","journal-title":"Nano Today"},{"issue":"24","key":"10.1016\/j.phrs.2023.106740_bib57","doi-asserted-by":"crossref","first-page":"15279","DOI":"10.1021\/acs.jmedchem.0c01336","article-title":"Cancer Stem Cell (CSC) inhibitors in oncology\u2014a promise for a better therapeutic outcome: state of the art and future perspectives","volume":"63","author":"Kharkar","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2023.106740_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121180","article-title":"A novel prodrug and its nanoformulation suppress cancer stem cells by inducing immunogenic cell death and inhibiting indoleamine 2, 3-dioxygenase","volume":"279","author":"Guan","year":"2021","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.phrs.2023.106740_bib59","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ccr.2010.08.009","article-title":"Targeting mitochondrial glutaminase activity inhibits oncogenic transformation","volume":"18","author":"Wang","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phrs.2023.106740_bib60","doi-asserted-by":"crossref","first-page":"11321","DOI":"10.1038\/ncomms11321","article-title":"The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy","volume":"7","author":"Lukey","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2023.106740_bib61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ebiom.2018.11.063","article-title":"Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt\/beta-catenin pathway","volume":"39","author":"Li","year":"2019","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.phrs.2023.106740_bib62","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1021\/acs.chemmater.1c03346","article-title":"Influence of linkers within stimuli-responsive prodrugs on cancer therapy: a case of five doxorubicin dimer-based nanoparticles","volume":"34","author":"Wang","year":"2022","journal-title":"Chem. Mater."},{"issue":"15","key":"10.1016\/j.phrs.2023.106740_bib63","doi-asserted-by":"crossref","first-page":"2100233","DOI":"10.1002\/advs.202100233","article-title":"Hyperbaric oxygen boosts PD-1 antibody delivery and T cell infiltration for augmented immune responses against solid tumors","volume":"8","author":"Liu","year":"2021","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2023.106740_bib64","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1038\/s41467-020-16403-5","article-title":"UDP-glucosyltransferase regulates grain size and abiotic stress tolerance associated with metabolic flux redirection in rice","volume":"11","author":"Dong","year":"2020","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.phrs.2023.106740_bib65","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s00216-011-4764-2","article-title":"Mitochondrial ROS production under cellular stress: comparison of different detection methods","volume":"400","author":"Kuznetsov","year":"2011","journal-title":"Anal. Bioanal. Chem."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823000968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823000968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:43:35Z","timestamp":1760913815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661823000968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":65,"alternative-id":["S1043661823000968"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106740","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel lonidamine derivative targeting mitochondria to eliminate cancer stem cells by blocking glutamine metabolism","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106740"}}